Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Structural characterization by NMR of a double phosphorylated chimeric peptide vaccine for treatment of Alzheimer's disease.

Ramírez-Gualito K, Richter M, Matzapetakis M, Singer D, Berger S.

Molecules. 2013 Apr 26;18(5):4929-41. doi: 10.3390/molecules18054929.

2.

Rational design of multiple TB antigens TB10.4 and TB10.4-Ag85B as subunit vaccine candidates against Mycobacterium tuberculosis.

Shi S, Yu L, Sun D, Liu J, Hickey AJ.

Pharm Res. 2010 Feb;27(2):224-34. doi: 10.1007/s11095-009-9995-y. Epub 2009 Oct 28.

PMID:
19862606
3.

A Phosphorylation-Induced Turn Defines the Alzheimer's Disease AT8 Antibody Epitope on the Tau Protein.

Gandhi NS, Landrieu I, Byrne C, Kukic P, Amniai L, Cantrelle FX, Wieruszeski JM, Mancera RL, Jacquot Y, Lippens G.

Angew Chem Int Ed Engl. 2015 Jun 1;54(23):6819-23. doi: 10.1002/anie.201501898. Epub 2015 Apr 16.

PMID:
25881502
4.

Characterization of the AT180 epitope of phosphorylated Tau protein by a combined nuclear magnetic resonance and fluorescence spectroscopy approach.

Amniai L, Lippens G, Landrieu I.

Biochem Biophys Res Commun. 2011 Sep 9;412(4):743-6. doi: 10.1016/j.bbrc.2011.08.046. Epub 2011 Aug 17.

PMID:
21871442
6.

Role of phosphorylation in the conformation of tau peptides implicated in Alzheimer's disease.

Daly NL, Hoffmann R, Otvos L Jr, Craik DJ.

Biochemistry. 2000 Aug 1;39(30):9039-46.

PMID:
10913317
7.

Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.

D'Souza S, Rosseels V, Romano M, Tanghe A, Denis O, Jurion F, Castiglione N, Vanonckelen A, Palfliet K, Huygen K.

Infect Immun. 2003 Jan;71(1):483-93.

8.

Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.

Bennekov T, Dietrich J, Rosenkrands I, Stryhn A, Doherty TM, Andersen P.

Eur J Immunol. 2006 Dec;36(12):3346-55.

9.

Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein.

Porzig R, Singer D, Hoffmann R.

Biochem Biophys Res Commun. 2007 Jun 29;358(2):644-9. Epub 2007 May 7.

PMID:
17499212
11.

Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.

Li Q, Yu H, Zhang Y, Wang B, Jiang W, Da Z, Xian Q, Wang Y, Liu X, Zhu B.

Scand J Immunol. 2011 Jun;73(6):568-76. doi: 10.1111/j.1365-3083.2011.02531.x.

12.
13.
14.

Identification of amino acid residues of the T-cell epitope of Mycobacterium tuberculosis alpha antigen critical for Vbeta11(+) Th1 cells.

Kariyone A, Higuchi K, Yamamoto S, Nagasaka-Kametaka A, Harada M, Takahashi A, Harada N, Ogasawara K, Takatsu K.

Infect Immun. 1999 Sep;67(9):4312-9.

15.
16.

Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.

Hoffmann R, Lee VM, Leight S, Varga I, Otvos L Jr.

Biochemistry. 1997 Jul 1;36(26):8114-24.

PMID:
9201960
17.

Positional effects of phosphorylation on the stability and morphology of tau-related amyloid fibrils.

Inoue M, Konno T, Tainaka K, Nakata E, Yoshida HO, Morii T.

Biochemistry. 2012 Feb 21;51(7):1396-406. doi: 10.1021/bi201451z. Epub 2012 Feb 7.

PMID:
22304362
18.

Hyperphosphorylation of tau induces local polyproline II helix.

Bielska AA, Zondlo NJ.

Biochemistry. 2006 May 2;45(17):5527-37.

PMID:
16634634
19.
20.

Chimaeric protein improved immunogenicity compared with fusion protein of Ag85B and ESAT-6 antigens of Mycobacterium tuberculosis.

Xu Y, Wang B, Chen J, Wang Q, Zhu B, Shen H, Qie Y, Wang J, Wang H.

Scand J Immunol. 2006 Nov;64(5):476-81.

Items per page

Supplemental Content

Write to the Help Desk